Evening Primrose Oil 220 Capsules

Buy 5-pack SAVE 10%

Products Information

Evening Primrose Oil is a natural extract that may be helpful in the relief of pre-menstrual and menopausal symptoms. It may promote you quality of life.Evening Primrose Oil (EPO) is a rich natural source of Omega-6 essential, fatty acids (EFAs), Gamma-linolenic Acid (GLA) and Linoleic Acid (LA). GLA is essential for production of prostaglandins, hormone-like substances, which
regulate many important body functions including cholesterol levels, joint
health, circulation and skin condition.

Dosage

Adults – Take 1-3 capsules daily with food, or as professionally prescribed.

Ingredients

Organic Evening Primrose Oil 1000 mg
Providing:
Gamma-linolenic Acid (GLA) 100 mg
Linoleic Acid (LA) 700 mg
d-Alpha Tocopheryl (Vitamin E) 5 iu
The organic, cold-pressed evening primrose oil used in this product is certified
by the USDA National Organic Program and ECOCERT SA.

Note

Store below 30º C in a cool dry place.

What is EPO?

Evening primrose oil is the oil from the seed of the evening primrose plant. Evening Primrose Oil (EPO) is a rich natural source of Omega-6 essential fatty acids (EFAs), Gamma-linolenic Acid (GLA) and Linoleic Acid (LA). GLA is essential for production of prostaglandins, hormone-like substances, which regulate many important body functions including cholesterol levels, joint health, circulation and skin condition.

References:

http://www.nlm.nih.gov/medlineplus/druginfo/natural/1006.html

Aragona P., Bucolo C., Spinella R., Giuffrida S., Ferreri G., Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren’s syndrome patients, Invest Ophthalmol Vis Sci. 2005 Dec; 46 (12): 4474-9.
Belch J.J., Ansell D., Madhok R., O’Dowd A., Sturrock R.D., Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study, Ann Rheum Dis. 1988 Feb; 47 (2): 96-104.
Belch J.J., Shaw B., O’Dowd A., Saniabadi A., Leiberman P., Sturrock R.D., Forbes C.D., Evening primrose oil (Efamol) in the treatment of Raynaud’s phenomenon: a double blind study, Thromb Haemost. 1985 Aug 30; 54 (2): 490-4.
Bordoni A., Biagi P.L., Masi M., Ricci G., Fanelli C., Patrizi A., Ceccolini E., Evening primrose oil (Efamol) in the treatment of children with atopic eczema, Drugs Exp Clin Res. 1988; 14 (4): 291-7.
Brzeski M., Madhok R., Capell H.A., Evening primrose oil in patients with rheumatoid arthritis and side effects of non-steroidal anti-inflammatory drugs, Br J Rheumatol. 1991 Oct; 30 (5): 370-2.
Cheng Z., Abayasekara D.R., Wathes D.C., The effect of supplementation with n-6 polyunsaturated fatty acids on 1-,2-, and 3-series prostaglandin F production by ovine uterine epithelial cells, Biochim Biophys Acta. 2005 Sep 15; 1736 (2): 128-35.
Cheung K.L., Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia, Aust N Z J Surg. 1999 Jul; 69 (7): 492-4.
Dippenaar N., Booyens J., Fabbri D., Katzef I.E., The reversibility of cancer: evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent, S Afr Med J. 1982 Oct 2; 62 (15): 505-9.
Engler M.M., Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats, Prostaglandins Leukot Essent Fatty Acids. 1993 Oct; 49 (4): 809-14.
Greenfield S.M., Green A.T., Teare J.P., Jenkins A.P., Punchard N.A., Ainley C.C. Thompson R.P., A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis, Aliment Pharmacol Ther. 1993 Apr; 7 (2): 159-66.
GNC Healthnotes: htpp://www.gnc.com
Hornych A., Oravec S., Girault F., Forette B., Horrobin D.F., The effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandin synthesis in older subjects, Bratisl Lek Listy. 2002; 103 (3): 101-7.
Horrobin D.F., Essential fatty acid and prostaglandin metabolism in Sjogren’s syndrome, systemic sclerosis and rheumatoid arthritis, Scand J Rheumatol Suppl. 1986; 61: 242-5.
Horrobin D.F., Essential fatty acid metabolism and its modification in atopic eczema, Am J Clin Nutr. 2000 Jan; 71 (1 Supple): 367S-72S.
Horrobin D.F., Prostaglandin E1: physiological significance and clinical use, Wien Klin Wochenschr. 1988 Jul 15; 100 (14): 471-7.
Horrobin D.F., The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism, Prostaglandins Leukot Essent Fatty Acids. 1992 May; 46 (1): 71-7.
Horrobin D.F., The role of essential fatty acids and prostaglandins in the premenstrual syndrome, J Reprod Med. 1983 Jul; 28 (7): 465-8.
Horrobin D.F., Manku M.S., Oka M., Morgan R.O., Cunnane S.C., Ally A.I., Ghayur T., Schweitzer M., Karmali R.A., The nutritional regulation of T lymphocyte function, Med Hypotheses. 1979 Sep; 5 (9): 969-85.
Ishikawa T., Fujiyama Y., Igarashi O., Morino M., Tada N., Kagami A., Sakamoto T., Nagano M., Nakamura H., Effects of gammalinolenic aicd on plasma lipoproteins and apolipoproteins, Atherosclerosis. 1989 Feb; 75 (2-3): 95-104.
Jamal G.A., Carmichael H., The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial, Diabet Med. 1990 May; 7 (4): 319-23.
Schalin-Karrila M., Mattila L., Jansen C.T., Uotila P., Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipids fatty acids and circulating blood prostaglandins, Br J Dermatol. 1987 Jul; 117 (1): 11-9.
Vaddadi K.S., Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia, Prostaglandins Leukot Essent Fatty Acids. 1992 May; 46 (1): 67-70.
Villalobos M.A., De La Cruz J.P., Martin-Romero M., Carmona J.A., Smith-Agreda J.M., Sanchez de la Cuesta F., Effect of dietary supplementation with evening primrose oil on vascular thrombogenesis in hyperlipemic rabbits, Thromb Haemost. 1998 Oct; 80 (4): 696-701.
Watkins G., Martin T.A., Bryce R., Mansel R.E., Jiang W.G., Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells, Prostaglandins Leukot Essent Fatty Acids. 2005 Apr; 72 (4): 273-8.